This inventor holds 1 USPTO granted patent. Top assignee: Dong-A St Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Ha Yoon Kim: Innovator in Pharmaceutical Compounds
Introduction
Ha Yoon Kim is a notable inventor based in Hwaseong-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as GCN2 inhibitors. His work is crucial for advancing treatments for diseases related to GCN2 activity.
Latest Patents
Ha Yoon Kim holds 1 patent for his invention titled "Compounds as GCN inhibitors, pharmaceutical compositions and uses thereof." This patent details novel compounds, specifically those of Formula (I), which act as GCN2 inhibitors. The pharmaceutical compositions derived from these compounds can inhibit GCN2 activity, offering potential treatments for various diseases associated with this pathway.
Career Highlights
Kim is currently employed at Dong-a ST Co., Ltd., a company recognized for its commitment to pharmaceutical innovation. His role involves researching and developing new therapeutic compounds that can significantly impact patient care.
Collaborations
Throughout his career, Ha Yoon Kim has collaborated with talented individuals, including Cheonhyoung Park and Kimoon Ryu. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Ha Yoon Kim's contributions to pharmaceutical science, particularly through his innovative patent on GCN2 inhibitors, highlight his role as a key inventor in the industry. His work continues to pave the way for new therapeutic options in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile